417 related articles for article (PubMed ID: 14557437)
1. Contraceptive efficacy of a depot progestin and androgen combination in men.
Turner L; Conway AJ; Jimenez M; Liu PY; Forbes E; McLachlan RI; Handelsman DJ
J Clin Endocrinol Metab; 2003 Oct; 88(10):4659-67. PubMed ID: 14557437
[TBL] [Abstract][Full Text] [Related]
2. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
3. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
[TBL] [Abstract][Full Text] [Related]
4. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
Guerin JF; Rollet J
Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439
[TBL] [Abstract][Full Text] [Related]
6. Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception.
Anderson RA; Kinniburgh D; Baird DT
J Clin Endocrinol Metab; 2002 Aug; 87(8):3640-9. PubMed ID: 12161488
[TBL] [Abstract][Full Text] [Related]
7. Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men.
McLachlan RI; O'Donnell L; Stanton PG; Balourdos G; Frydenberg M; de Kretser DM; Robertson DM
J Clin Endocrinol Metab; 2002 Feb; 87(2):546-56. PubMed ID: 11836283
[TBL] [Abstract][Full Text] [Related]
8. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
[TBL] [Abstract][Full Text] [Related]
9. Reversible azoospermia induced by an androgen-progestin combination regimen in Indonesian men.
Pangkahila W
Int J Androl; 1991 Aug; 14(4):248-56. PubMed ID: 1831798
[TBL] [Abstract][Full Text] [Related]
10. Rates of suppression and recovery of human sperm output in testosterone-based hormonal contraceptive regimens.
Ly LP; Liu PY; Handelsman DJ
Hum Reprod; 2005 Jun; 20(6):1733-40. PubMed ID: 15860500
[TBL] [Abstract][Full Text] [Related]
11. Suppression of human spermatogenesis by testosterone implants.
Handelsman DJ; Conway AJ; Boylan LM
J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094
[TBL] [Abstract][Full Text] [Related]
12. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
Behre HM; Nashan D; Hubert W; Nieschlag E
J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
[TBL] [Abstract][Full Text] [Related]
13. Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception.
Brady BM; Walton M; Hollow N; Kicman AT; Baird DT; Anderson RA
Hum Reprod; 2004 Nov; 19(11):2658-67. PubMed ID: 15333595
[TBL] [Abstract][Full Text] [Related]
14. Spermatogenetic inhibition in men taking a combination of oral medroxyprogesterone acetate and percutaneous testosterone as a male contraceptive method.
Soufir JC; Meduri G; Ziyyat A
Hum Reprod; 2011 Jul; 26(7):1708-14. PubMed ID: 21551452
[TBL] [Abstract][Full Text] [Related]
15. Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.
Page ST; Amory JK; Anawalt BD; Irwig MS; Brockenbrough AT; Matsumoto AM; Bremner WJ
J Clin Endocrinol Metab; 2006 Nov; 91(11):4374-80. PubMed ID: 16940442
[TBL] [Abstract][Full Text] [Related]
16. Suppression of spermatogenesis by testosterone enanthate in Thai men.
Aribarg A; Sukcharoen N; Chanprasit Y; Ngeamvijawat J; Kriangsinyos R
J Med Assoc Thai; 1996 Oct; 79(10):624-9. PubMed ID: 8996996
[TBL] [Abstract][Full Text] [Related]
17. Contraceptive efficacy and adverse effects of testosterone enanthate in Thai men.
Sukcharoen N; Aribarg A; Kriangsinyos R; Chanprasit Y; Ngeamvijawat J
J Med Assoc Thai; 1996 Dec; 79(12):767-73. PubMed ID: 9071080
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
Matsumoto AM
J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
[TBL] [Abstract][Full Text] [Related]
20. A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men.
Gu YQ; Wang XH; Xu D; Peng L; Cheng LF; Huang MK; Huang ZJ; Zhang GY
J Clin Endocrinol Metab; 2003 Feb; 88(2):562-8. PubMed ID: 12574181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
